Stefanie Geisler is a Neurology physician affiliated with Washington University in St. Louis. OpenAlex indexes 17 publications with 217 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4921 Parkview Pl
Div Neurology Neuromuscular, Ste 6c
Saint Louis, MO 631101032
Telephone
314-362-1408Registry record last updated 17 Apr 2025.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
72.2%Gabapentinoids33.5%Gabapentin53%Pregabalin47%Part D<11 patientsSNRI10.5%Duloxetine Hcl100%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
21.8%Corticosteroid21.8%Prednisone100%Part D≥11 patientsCancer & immunology
6%Purine Antimetabolite6%Azathioprine100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2015–2026 per NIH RePORTER. The latest:
- Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy
Washington University
FY2026$377,467R37CA267905 - Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy
Washington University
FY2025$419,407R37CA267905 - Developing mechanism-based strategies to treat chemotherapy-induced peripheral neuropathy
Washington University
FY2024$396,506R37CA267905
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Uncovering Hidden Profiles: From Pain‐Centric to Multi‐Symptom Small Fiber Neuropathy
European Journal of Neurology
2025 - Investigation of cis-4-[18F]Fluoro-D-Proline Uptake in Human Brain Tumors After Multimodal Treatment
Molecular Imaging and Biology
2018
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Ley, MD
Washington University in St. Louis
David Gutmann, MD
Washington University in St. Louis
Randall Bateman, MD
Washington University in St. Louis
Victoria Fraser, MD
Washington University in St. Louis
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”